Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank14
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-158.35M
↓ 158% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-61.36M
Historical baseline
PeriodValueYoY Change
2025$-158.35M+6.0%
2024$-168.38M-23.9%
2023$-135.96M-17.3%
2022$-115.91M-195.6%
2021$121.19M+1207.1%
2020$-10.95M+18.7%
2019$-13.46M-48.5%
2018$-9.06M-